STERIS plc (NYSE:STE) is one of the best medical technology stocks to invest in. On February 5, Citizens reiterated its ...
STERIS plc has reported past third-quarter 2025 results showing sales of US$1,496.2 million and net income of US$192.9 million, with earnings per share rising versus the prior year, and also confirmed ...
And I do have a few words to caution before we open for comments. Any redistribution, retransmission, or rebroadcast of this ...
STERIS plc is rated a Buy, offers a resilient, high-quality business model with some premium valuation. Learn more about STE ...
Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% As reported EPS from continuing operations ...
Medical equipment and services company Steris (NYSE:STE). in Q4 CY2025, with sales up 9.2% year on year to $1.50 billion. Its ...
Medical equipment company Steris (NYSE: STE) plans to eliminate less than 300 positions as part of a previously announced restructuring plan. Steris said in an SEC filing last week that the move comes ...
Steris plc remains a Strong Buy with a fair value of $281, supported by robust organic growth and margin expansion. The Trump administration's push to reshore pharma manufacturing could be a major ...
Mentor, Ohio-based STERIS plc (STE) provides infection prevention products and services worldwide. With a market cap of $20.3 billion, STERIS operates through Healthcare, Applied Sterilization ...
MENTOR, Ohio -- Steris Corp., a global medical company based in Mentor, plans to buy next-door neighbor US Endoscopy for $270 million in cash, a deal that highlights two locally grown companies that ...
DUBLIN, IRELAND, Jan. 28, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The ...
STERIS stock (NYSE: STE), a healthcare company focused on infection prevention, has seen a 29% fall this year, slightly underperforming the broader S&P500 index, down 21%. However, in the longer term, ...